Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cellares Corporation
Manufacturing
Cellares attracts $257M series D to build sites in Japan, Europe
With Cellares preparing to begin commercial production in 2027, the cell therapy contract manufacturer has raised $257 million in a series D round.
Kevin Dunleavy
Jan 28, 2026 9:40am
Cellares expands to Europe with new facility in the Netherlands
Jan 12, 2026 2:24pm
FDA grants advanced manufacturing tag to Ori's IRO platform
Sep 3, 2025 4:00pm
Cellares' cell therapy production tech wins key FDA designation
Apr 2, 2025 9:40am
Kite will evaluate Cellares' cell therapy manufacturing platform
Jun 27, 2024 8:00am
BMS signs $380M deal with cell therapy manufacturer Cellares
Apr 22, 2024 11:10am
